FDA may tighten rules for drug advertising

09/22/2005 | Reuters

The FDA may tighten rules on drug advertising by requiring pre-approval by the agency and setting new guidelines on how much risk information should be included in the ads. The changes are to be discussed in November when the agency holds a two-day public meeting.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX